Gene · 442917
Papers1,370
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,370
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| INTEGRATED ANALYSIS OF ERΑ, TP53, AND PGR PROTEINS WITH MIR-372, MIR-373, AND MIR-519D DYSREGULATION IN FEMALE BREAST CANCER. | Georgian Med News | 2026 | 42107952 | PubTator, text mining | PubMed |
| Analysis of morphological, morphokinetics, cell-free DNA, microRNAs parameters to predict aneuploidy status of embryos. | PLoS One | 2026 | 41926475 | PubTator, text mining | PubMed |
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | 41756253 | PubTator, text mining | PubMed |
| Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance. | Int J Mol Sci | 2026 | 41752055 | PubTator, text mining | PubMed |
| CXCR4: A Promising Novel Strategy for Lung Cancer Treatment. | Biomolecules | 2026 | 41750259 | PubTator, text mining | PubMed |
| MicroRNA Signatures of Prostate Cancer Spheroids in Microfluidic Culture Under Hormone-Deprivation Conditions. | Bioengineering (Basel) | 2026 | 41749743 | PubTator, text mining | PubMed |
| DistRMI: a deep distance-aware neural network for explainable RNA loop motif-small molecule interaction prediction. | Brief Bioinform | 2025 | 41364671 | PubTator, text mining | PubMed |
| The mir-371a-373 cluster: A crucial miRNA cluster promotes the malignancy of gastric cancer. | Neoplasma | 2025 | 41017651 | PubTator, text mining | PubMed |
| Bibliometric analysis of research on cervical cancer and miRNAs from 2010 to 2024: research trends, hotspots, and prospects. | Discov Oncol | 2025 | 40864203 | PubTator, text mining | PubMed |
| [Retracted] miR-372 promotes breast cancer cell proliferation by directly targeting LATS2. | Exp Ther Med | 2025 | 40746446 | PubTator, text mining | PubMed |
| Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypes. | Breast Cancer Res Treat | 2025 | 40425926 | PubTator, text mining | PubMed |
| A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications. | Front Cell Dev Biol | 2025 | 40406420 | PubTator, text mining | PubMed |
| Dynamic role of long noncoding RNA in liver diseases: pathogenesis and diagnostic aspects. | Clin Exp Med | 2025 | 40369230 | PubTator, text mining | PubMed |
| The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation. | Medicina (Kaunas) | 2025 | 40142286 | PubTator, text mining | PubMed |
| The evolution and application of RNA-focused small molecule libraries. | RSC Chem Biol | 2025 | 39957993 | PubTator, text mining | PubMed |
| Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer. | Sci Rep | 2025 | 39881138 | PubTator, text mining | PubMed |
| Investigating the Imperative Role of microRNAs Expression in Human Embryo Implantation: A Narrative Review Based on Recent Evidence. | Biomedicines | 2024 | 39595182 | PubTator, text mining | PubMed |
| Screening of CAD-related secretory genes associated with type II diabetes based on comprehensive bioinformatics analysis and machine learning. | BMC Cardiovasc Disord | 2024 | 39501130 | PubTator, text mining | PubMed |
| LncRNA HOXA‑AS2 promotes the progression of epithelial ovarian cancer via the regulation of miR‑372. | Oncol Lett | 2024 | 38966577 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442917/papers